TCT-377 Use of Direct Oral Anticoagulation Therapy Alone Versus DOAC in Conjunction With Aspirin for Anticoagulation Following Implantation of the Watchman Left Atrial Appendage Closure Device

Autor:	Joseph Aragon, Jessica Quintos, Benita Tjoe, Hoang Nguyen, Michael Shenoda
Rok vydání:	2019
Předmět:	medicine.medical_specialty Aspirin Standard of care business.industry medicine.medical_treatment Warfarin Left atrial appendage occlusion Surgery Left atrial medicine cardiovascular diseases Cardiology and Cardiovascular Medicine business Oral anticoagulation medicine.drug
Zdroj:	Journal of the American College of Cardiology. 74:B374
ISSN:	0735-1097
Popis:	The current standard of care following left atrial appendage occlusion (LAAO) with the Watchman device (Boston Scientific) is 45 days of warfarin followed by dual antiplatelet therapy for 6 months and lifelong aspirin. There is a paucity of data regarding the use of direct oral anticoagulants (DOAC
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e02915b5d533a7f92be54686ca68cd53 https://doi.org/10.1016/j.jacc.2019.08.465 Zobrazit plný text záznamu